Candriam SCA’s TNF Pharmaceuticals, Inc. Common Stock TNFA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6
| Closed | -$114K | – | 918 |
|
|
2021
Q2 | $114K | Hold |
6
| – | – | ﹤0.01% | 845 |
|
|
2021
Q1 | $69K | Hold |
6
| – | – | ﹤0.01% | 771 |
|
|
2020
Q4 | $72K | Hold |
6
| – | – | ﹤0.01% | 785 |
|
|
2020
Q3 | $81K | Hold |
6
| – | – | ﹤0.01% | 775 |
|
|
2020
Q2 | $126K | Buy |
6
+3
| +100% | +$63K | ﹤0.01% | 761 |
|
|
2020
Q1 | $51K | Hold |
3
| – | – | ﹤0.01% | 768 |
|
|
2019
Q4 | $52K | Hold |
3
| – | – | ﹤0.01% | 787 |
|
|
2019
Q3 | $174K | Hold |
3
| – | – | ﹤0.01% | 736 |
|
|
2019
Q2 | $174K | Hold |
3
| – | – | ﹤0.01% | 798 |
|
|
2019
Q1 | $377K | Buy |
3
+1
| +50% | +$126K | ﹤0.01% | 747 |
|
|
2018
Q4 | $367K | Buy |
2
+1
| +100% | +$184K | 0.01% | 726 |
|
|
2018
Q3 | $348K | Buy |
+1
| New | +$348K | ﹤0.01% | 747 |
|